Effect of Shenfu injection on prognosis and quality of life of patients with vasovagal syncope
10.3760/cma.j.issn.1673-4246.2019.10.005
- VernacularTitle: 参附注射液辅助西医综合疗法对血管迷走神经性晕厥患者预后及生活质量的影响
- Author:
Huijuan JIANG
1
;
Renli CHENG
;
Tingting WANG
;
Ting YU
;
Yadong SHANG
Author Information
1. Department of Emergency, Suzhou Affiliated Hospitial of Anhui Medical University, Suzhou 234000, China
- Publication Type:Clinical Trail
- Keywords:
Syncope, vasovagal;
Tilt-Table test;
Shenfu injection;
Quality of life;
Prognosis
- From:
International Journal of Traditional Chinese Medicine
2019;41(10):1058-1061
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the effect of different doses of Shenfu injection on prognosis and quality of life for patients with vasovagal syncope (VVS).
Methods:A total of 126 patients were randomly divided into 3 groups. The control group (n=38) were treated by western medicine comprehensive therapy with tilting training. The low and high dose Shenfu injection groups were treated by Shenfu injection 40 ml/d (n=44) and 120 ml/d (n=44) on the treatment basis of control group. All the groups were treated for 14 days. The patients were followed up for 1 year after discharge. The relapse rate of syncope, quality of life social support rating scale (SSRS), effective rate of treatment, time of stable blood pressure, time of stable heart rate, recovery time of autonomic nervous disorder and adverse reactions were observed in each groups.
Results:The total effective rate was 47.4% (18/38) in the control group, 72.7% (32/44) in the low dose group, and 90.9% (40/44) in the high dose group. The difference between the three groups was statistically significant (χ2=18.997, P<0.01), and the total effective rate of Shenfu injection high-dose group was significantly higher than that of low-dose group (P<0.05). After treatment, there were significant differences in the recovery time of blood pressure, heart rate and autonomic nervous disorder among the three groups (F=19.165, 158.428, 33.405, P<0.01). The above indicators in the high dose group of Shenfu injection were significantly higher than the low dose group (t=-4.020, -5.180, -5.307, P<0.05). After 1 year of follow-up, the recurrence rate of the control group was 61.1% (11/18), the low-dose group was 18.8% (6/32), and the high-dose group was 5% (2/40), where there was significant difference among all the groups (χ2=20.886, P<0.01). The quality of life scores were compared for 1 year among the 3 groups, and the difference was statistically significant (F=23.025, P<0.01).
Conclusions:The Shenfu injection combined with Western medicine comprehensive therapy can improve the prognosis and quality of life of patients with VVS, and the improvement of each indicator of daily dosage of 120 ml is better than the daily dosage of 40 ml Shenfu injection.
